's Avatar

@eickelbergmd.bsky.social

33 Followers  |  14 Following  |  1 Posts  |  Joined: 07.12.2024  |  1.4077

Latest posts by eickelbergmd.bsky.social on Bluesky

Thanks for inviting us to @yalepccsm.bsky.social ๐Ÿ™. Wonderful to meet you and so many friends!

10.04.2025 03:02 โ€” ๐Ÿ‘ 3    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Post image

Our current issue's special collection of Physician-Scientist Development articles includes an editorial by Editor in chief @eickelbergmd.bsky.social & is paired with a cover collage of children's drawings illustrating what a 'physician-scientist' means to them: buff.ly/mWGTpMV

08.04.2025 17:38 โ€” ๐Ÿ‘ 3    ๐Ÿ” 2    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Post image

@markesnyder.bsky.social et al. flip the script on our understanding of infection and rejection after transplantationโ€“ they show that systemic NKG2D blockade can impair airway-associated Tissue resident memory T cell accumulation and reduce CLAD severity: buff.ly/61mpbwk

06.03.2025 16:13 โ€” ๐Ÿ‘ 2    ๐Ÿ” 2    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 1
graphic depicts that lung alveolar macrophages loss of peroxisome drives the process

graphic depicts that lung alveolar macrophages loss of peroxisome drives the process

Just published @science.org
A basisโ€”lung inflammationโ€”for #LongCovid (PASC) in the experimental model, and a potential therapy
[driven by alveolar macrophages and loss of their peroxisomes (Figure)]
www.science.org/doi/10.1126/...
www.science.org/doi/10.1126/...

06.03.2025 19:00 โ€” ๐Ÿ‘ 372    ๐Ÿ” 123    ๐Ÿ’ฌ 15    ๐Ÿ“Œ 7
Post image

Emanual Maverakis et al. use single-cell and bulk RNA-seq and immunohistochemistry to characterize necrobiosis and identified SPP1 and CCL5 as novel therapeutic targets for NL and NXG, rare diseases without a highly effective therapy: buff.ly/7htsyLe

04.03.2025 16:13 โ€” ๐Ÿ‘ 2    ๐Ÿ” 2    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Post image 14.12.2024 02:04 โ€” ๐Ÿ‘ 12186    ๐Ÿ” 1123    ๐Ÿ’ฌ 270    ๐Ÿ“Œ 110

@eickelbergmd is following 14 prominent accounts